Graig Suvannavejh

Stock Analyst at Mizuho

(0)
# 4252
Out of 5,270 analysts
168
Total ratings
42.05%
Success rate
-7.99%
Average return
45 Stocks
Name Action Price Target Current % Upside Ratings Updated
Axsome Therapeutics
Maintains: Outperform
195 212
127.09 66.81% 20 Feb 26, 2025
Intra-Cellular Thera...
Downgrades: Neutral
140 132
131.27 0.56% 10 Feb 24, 2025
Harmony Biosciences
Maintains: Outperform
52 42
32.21 30.39% 16 Feb 20, 2025
Adaptimmune Therapeu...
Maintains: Outperform
3 2
0.52 188.46% 2 Nov 27, 2024
Autolus Therapeutics
Upgrades: Buy
7 8
1.74 336.78% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
72 38
28.89 31.53% 7 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
39 38
24.12 57.55% 6 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 74
6.9 972.46% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5 1
0.37 35.14% 3 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
44 49
57.92 -15.4% 6 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
19.09 161.92% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
1.42 1308.45% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
36 82
76.19 7.63% 6 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 16
4.2 280.95% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 3
3.06 -1.96% 5 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
39 30
5.72 424.48% 4 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 22
4.16 428.85% 4 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 8
1.48 440.54% 1 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 4
3.96 -11.62% 1 Mar 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25 45
n/a n/a 9 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 10
3.4 194.12% 5 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 9
1.42 533.8% 4 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
64
3.81 1579.79% 8 Aug 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
274 258
n/a n/a 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 1
2.18 -54.13% 5 Jun 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
2.19 584.93% 1 Mar 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 35
52.36 -33.16% 5 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 8
3.91 104.6% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
71 57
42.92 32.81% 2 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
8 5
34.41 -85.47% 4 Apr 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
n/a n/a 2 Oct 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 6
n/a n/a 2 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
53
n/a n/a 1 Jul 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
6.99 386.41% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
28
4.5 522.22% 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
25.47 21.71% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
19
0.97 1858.76% 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
5
2.13 123% 1 Nov 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
36
12.79 181.47% 2 Nov 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 1 Oct 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
37
0.71 5111.27% 1 Oct 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
128
140.19 -8.7% 1 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 10
n/a n/a 1 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
29
n/a n/a 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
35
n/a n/a 1 Jan 8, 2020